Board and Committee Changes

Released : 06.05.2021 17:50

RNS Number : 8440X GlaxoSmithKline PLC 06 May 2021

GlaxoSmithKline plc

GSK announces changes to its Board and Committees

GlaxoSmithKline plc today announces the following changes to its Board and Committee membership effective 6 May 2021.

As previously announced, Dr Anne Beal has joined the Board as an Independent Non-Executive Director. She has been appointed a member of the Corporate Responsibility Committee.

In addition, Charles Bancroft has been appointed a member of the Nominations & Corporate Governance and Science Committees. These appointments are in addition to his role as Chairman of the Audit & Risk Committee and membership of the Transformation & Separation Committee.

Note

1. From 6 May 2021 the Board of GSK comprises

Sir Jonathan Symonds Non-Executive Chairman Chief Executive Officer Iain Mackay Chief Financial Officer Dr Hal Barron Chief Scientific Officer and President, R&D Vindi Banga Senior Independent Non-Executive Director Charles Bancroft Independent Non-Executive Director Dr Anne Beal Independent Non-Executive Director Dr Independent Non-Executive Director Independent Non-Executive Director Dr Jesse Goodman Independent Non-Executive Director Dr Independent Non-Executive Director Independent Non-Executive Director

V A Whyte Company Secretary

6 May 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOABLGDUCSGDGBL